Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Orphanet J Rare Dis ; 17(1): 246, 2022 06 23.
Artigo em Inglês | MEDLINE | ID: mdl-35739601

RESUMO

BACKGROUND: Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic microangiopathy (TMA) requiring urgent treatment. Standardization of its diagnosis and optimal management is challenging. This study aimed to evaluate the role of centralized, rapid testing of ADAMTS13 in patients experiencing acute TMAs requiring plasma-exchange (PEX) and to estimate the incidence of TTP in a large Italian Region. METHODS: We perfomed a cohort study in the frame of the project "Set-up of a Lombardy network for the study and treatment of patients undergoing apheresis", including 11 transfusion centers in the Region. Consecutive patients referred from 2014 to 2016 with acute TMAs requiring PEX were enrolled. Centralized ADAMTS13 activity testing was performed at the Milan Hemophilia and Thrombosis Center within 24 h. RESULTS: Forty-three TMA patients (44 events) were enrolled, of whom 35 (81%) had severe ADAMTS13 deficiency. Patients with severe ADAMTS13 deficiency were younger, mainly women, with a higher prevalence of autoimmune disorders and a lower prevalence of cancer. Clinical and laboratory characteristics of patients with and without severe ADAMTS13 deficiency largely overlapped, with a lower platelet count being the only baseline marker that significantly differed between the two patient groups (ADAMTS13 activity < 10% vs ≥ 10%: median difference of -27 × 109/l, 95% CI - 37 to - 3). PEX treatment was initiated in all patients, but soon discontinued in cases without severe ADAMTS13 deficiency. In this group, the mortality rate was higher and no episode exacerbations or relapses within 6 months occured. The estimated average annual incidence of acute acquired TTP events was 1.17 [0.78-1.55] per million people. CONCLUSIONS: Severe ADAMTS13 deficiency distinguished two groups of patients with largely overlapping clinical features but different treatment and disease course. This study provides a feasible model implemented in a large Italian region for the practical clinical approach to TMAs and underlines the importance of urgent ADAMTS13 activity testing for an accurate differential diagnosis and therapeutic approach.


Assuntos
Proteína ADAMTS13 , Púrpura Trombocitopênica Trombótica , Trombose , Microangiopatias Trombóticas , Proteína ADAMTS13/deficiência , Estudos de Coortes , Feminino , Humanos , Troca Plasmática , Púrpura Trombocitopênica Trombótica/diagnóstico , Púrpura Trombocitopênica Trombótica/epidemiologia , Púrpura Trombocitopênica Trombótica/terapia , Microangiopatias Trombóticas/diagnóstico , Microangiopatias Trombóticas/epidemiologia , Microangiopatias Trombóticas/terapia
3.
Braz. j. morphol. sci ; 29(1): 1-17, Jan.-Mar. 2012.
Artigo em Inglês | LILACS | ID: lil-654231

RESUMO

The overall aim of this literature review is, by making use of major databases, to introduce the conceptsabout the articular cartilage structure and the effects of aging on articular cartilage. The effects of physicalexercises on those cartilages are also discussed. The most important observations found are: cartilage thicknessdecreases gradually with age as well the content of proteoglycans and water, and there is an increase and thecollagen fibrils, which may be associated with the increased rigidity and fragility of the articular cartilage. Whenproperly done, physical activities produce compressive stimuli which enhance the activity of chondrocytesincreasing its nuclear volume density per area, as well as the width of the layers leading to greater resistance tocompression. Another consequence is extracellular matrix hydration resulting in greater mechanical resistanceand elasticity and a consequent increase the number of collagen fibrils which generates greater resistance todeformation and implies less rigidity. These facts reduce the risk of breakdown of cartilage when it is subjectedto high mechanical demand.


Assuntos
Envelhecimento , Cartilagem Articular , Cartilagem Articular/anatomia & histologia , Exercício Físico , Atividade Motora
4.
Pediatr Med Chir ; 33(4): 196-8, 2011.
Artigo em Italiano | MEDLINE | ID: mdl-22423480

RESUMO

PURPOSE: Recessive distrofic epidermolysis bullosa creates severe hand deformities with disabling functional limitations. Hand surgeon should perform surgery when deformity inibits function, in order to restore the pinch. MATERIALS AND METHOD: We present our experience on 44 patients and 58 operated hands, with the following schema: hand degloving, grafting of the first web and intraoperative dynamic splinting. RESULTS: In 30 patient with an 8 years follow up, 25 had had good or excellent results, and the 5 remaining shows early recurrence. CONCLUSION: Association of a correct surgical approach and adequate intra and post-operative rehabilitation improve hand function and a slow down inevitable recurrence.


Assuntos
Epidermólise Bolhosa Distrófica/cirurgia , Deformidades Adquiridas da Mão/cirurgia , Procedimentos de Cirurgia Plástica , Contratura/cirurgia , Epidermólise Bolhosa Distrófica/genética , Epidermólise Bolhosa Distrófica/reabilitação , Seguimentos , Deformidades Adquiridas da Mão/genética , Deformidades Adquiridas da Mão/reabilitação , Humanos , Procedimentos de Cirurgia Plástica/métodos , Prevenção Secundária , Transplante de Pele/métodos , Resultado do Tratamento
5.
J Med Chem ; 39(18): 3569-84, 1996 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-8784456

RESUMO

ATP-citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. Inhibitors of the enzyme represent a potentially novel class of hypolipidemic agent, which are anticipated to have combined hypocholesterolemic and hypotriglyceridemic properties. A series of 2-substituted butanedioic acids have been designed and synthesized as inhibitors of the enzyme. The best compounds, 58, 68, 71, 74 have reversible Ki's in the 1-3 microM range against the isolated rat enzyme. As representative of this compound class, 58, has been shown to exert its inhibitory action through a mainly competitive mechanism with respect to citrate and a noncompetitive one with respect to CoA. None of the inhibitors were able to inhibit cholesterol and/or fatty acid synthesis in HepG2 cells. This has been attributed to the adverse physicochemical properties of the molecules leading to a lack of cell penetration. Despite this, a lead structural class of compound has been identified with the potential for modification into potent, cell-penetrant, and efficacious inhibitors of ATP-citrate lyase.


Assuntos
ATP Citrato (pro-S)-Liase/antagonistas & inibidores , Inibidores Enzimáticos/síntese química , Hipolipemiantes/síntese química , Animais , Desenho de Fármacos , Inibidores Enzimáticos/farmacologia , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases , Hipolipemiantes/farmacologia , Cinética , Ratos , Relação Estrutura-Atividade , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA